GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laekna Inc (HKSE:02105) » Definitions » Price-to-Free-Cash-Flow

Laekna (HKSE:02105) Price-to-Free-Cash-Flow : N/A (As of May. 16, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Laekna Price-to-Free-Cash-Flow?

As of today (2025-05-16), Laekna's share price is HK$14.16. Laekna's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.84. Hence, Laekna's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Laekna's Price-to-Free-Cash-Flow or its related term are showing as below:

HKSE:02105's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 29.53
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Laekna's Free Cash Flow per Share for the six months ended in Dec. 2024 was HK$-0.41. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$-0.84.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -8.80% per year.

During the past 4 years, Laekna's highest 3-Year average Free Cash Flow per Share Growth Rate was -8.80% per year. The lowest was -8.80% per year. And the median was -8.80% per year.


Laekna Price-to-Free-Cash-Flow Historical Data

The historical data trend for Laekna's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laekna Price-to-Free-Cash-Flow Chart

Laekna Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
- - - -

Laekna Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial - - - - -

Competitive Comparison of Laekna's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Laekna's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laekna's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laekna's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Laekna's Price-to-Free-Cash-Flow falls into.


;
;

Laekna Price-to-Free-Cash-Flow Calculation

Laekna's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=14.16/-0.841
=N/A

Laekna's Share Price of today is HK$14.16.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Laekna's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Laekna  (HKSE:02105) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Laekna Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Laekna's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Laekna Business Description

Traded in Other Exchanges
Address
No. 3-2-467, 5 Xingbin Road (Lin Li Center), Sino-Italy Ningbo Ecological Park, Zhejiang Province, Yuyao, CHN, 201203
Laekna Inc is a science-driven, clinical-stage biotechnology company. The company has established a comprehensive R&D infrastructure to accelerate the development of molecules from discovery to registrational trials. It has initiated one clinical trial and another five clinical trials for its Core Products LAE002 and LAE001. Among these six clinical trials, three multi-regional clinical trials (MRCTs) are designed to address medical needs in the standard of care (SOC)-resistant cancers. Laekna has two Core Products and 14 other pipeline product candidates. Core Product LAE002 is an adenosine triphosphate (ATP) competitive AKT inhibitor for the treatment of ovarian cancer, prostate cancer, breast cancer and PD-1/PD-L1 drug-resistant solid tumors.
Executives
Orbimed Advisors Iii Limited 2102 Investment manager
Orbimed Asia Gp Iii, L.p. 2102 Investment manager
Orbimed Asia Partners Iii, L.p. 2102 Investment manager
Zhong Yi Ning Bo Sheng Tai Yuan Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Guo Tou Zhao Shang Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin Er Qi You Xian He Huo 2101 Beneficial owner
Yu Yao Yang Ming Gu Quan Tou Zi Ji Jin You Xian Gong Si 2101 Beneficial owner
Laekna Wonderland Limited 2101 Beneficial owner
Lu Chris Xiangyang 2501 Other
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Jin Pu Yi Liao Jian Kang Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Gp Healthcare Capital, Inc. 2101 Beneficial owner
Liu Zeng 2201 Interest of corporation controlled by you
Ealex Llc 2101 Beneficial owner
Futu Trustee Limited 2301 Trustee

Laekna Headlines

No Headlines